simvastatin has been researched along with Pulmonary Arterial Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, P; Tang, B; Wang, H; Wang, X; Xu, J; Xuan, L; Zhang, H; Zhu, L | 1 |
| Absi, M; Ashton, N; Eid, BG; Gurney, AM; Hart, G | 1 |
2 other study(ies) available for simvastatin and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Simvastatin protects heart function and myocardial energy metabolism in pulmonary arterial hypertension induced right heart failure.
Topics: Animals; Energy Metabolism; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pulmonary Arterial Hypertension; Rats; Simvastatin | 2021 |
Simvastatin causes pulmonary artery relaxation by blocking smooth muscle ROCK and calcium channels: Evidence for an endothelium-independent mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium Channel Blockers; Calcium Channels; Disease Models, Animal; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type III; Phenylephrine; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Wistar; rho-Associated Kinases; Simvastatin | 2019 |